US Broker Ratings

Ardelyx, Inc. (ARDX) Investor Outlook: A Biotech Stock with a 124.58% Potential Upside

Ardelyx, Inc. (NASDAQ: ARDX), a burgeoning player in the biotechnology sector, has captured the attention of investors with its promising pipeline and significant upside potential. With..

Tectonic Therapeutic, Inc. (TECX) Investor Outlook: Analyzing the 358.60% Upside Potential

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a pioneering biotechnology company, stands at the forefront of therapeutic innovation with its cutting-edge GEODe technology platform. Specializing in the development..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a 79% Potential Upside

Talkspace, Inc. (NASDAQ: TALK), a pioneering virtual behavioral healthcare company, is capturing investor attention with a potential upside of 79.10%. Operating within the healthcare sector, Talkspace..

Claritev Corporation (CTEV) Stock Analysis: Eyeing a 20% Upside with Strong Buy Ratings

Claritev Corporation (NYSE: CTEV) is capturing investor attention in the healthcare sector, particularly in the Health Information Services industry. With a market capitalization of $1.09 billion,..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Potential 239% Upside Excites Investors

Cullinan Therapeutics, Inc. (NASDAQ: CGEM) is capturing the attention of investors with its significant potential upside, as analysts forecast a compelling 239.23% increase from its current..

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Contender with 54% Upside Potential

Keros Therapeutics, Inc. (NASDAQ: KROS) is emerging as a compelling opportunity in the biotech sector, with an impressive potential upside of 54.57% according to recent analyst..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Market

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, specializes in medical devices that cater to a diverse range of health needs. Headquartered..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 28.3% Potential Upside in Healthcare SaaS

HealthStream, Inc. (NASDAQ: HSTM), a prominent player in the healthcare sector, specializes in providing innovative Software-as-a-Service (SaaS) solutions tailored for healthcare organizations across the United States...

Mind Medicine (MNMD) Stock Analysis: Exploring the 99.75% Potential Upside in the Biotech Sector

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering company in the biotechnology sector, is capturing investor attention with an impressive market capitalization of $948.82 million. Based..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a 45.67% Potential Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA) is capturing attention in the healthcare sector with a distinct focus on pioneering engineered cell therapies. As a U.S.-based biotechnology company,..

Cronos Group Inc. (CRON) Stock Analysis: Evaluating a 20.5% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON), a notable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, has been making headlines due..

Day One Biopharmaceuticals, Inc (DAWN) Stock Analysis: Exploring a Potential 220% Upside

For investors seeking opportunities in the dynamic biotechnology sector, Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) offers a compelling narrative with its innovative approach to tackling childhood..

uniQure N.V. (QURE) Stock Analysis: Exploring the 26% Upside Potential in Biotechnology

As investors increasingly look toward biotechnology for promising growth opportunities, uniQure N.V. (NASDAQ: QURE) stands out with its noteworthy potential upside of 26.03%. Headquartered in Amsterdam,..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: A Potential Upside of 117.43% Sparks Investor Interest

Zevra Therapeutics, Inc. (NASDAQ: ZVRA) is capturing significant attention in the biotechnology sector with its robust pipeline focused on rare diseases and a compelling potential upside..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Exploring An 86% Upside Potential in Biotech

Arcus Biosciences, Inc. (NASDAQ: RCUS) is capturing the attention of investors with its substantial potential upside of 86.37%, as highlighted by analysts’ average price target of..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring the 96.51% Potential Upside for Investors

Arvinas, Inc. (NASDAQ: ARVN) is a name that has been capturing the attention of biotechnology investors, especially given its substantial potential upside of 96.51%. Operating within..

Definitive Healthcare Corp. (DH) Stock Analysis: Navigating a 53.81% Potential Upside in a Challenging Market

Definitive Healthcare Corp. (NASDAQ: DH), a leading provider of healthcare commercial intelligence through its SaaS platform, is capturing the attention of investors with its significant potential..

Arbutus Biopharma (ABUS) Investor Outlook: Exploring a 20.94% Upside with Innovative Hepatitis B Solutions

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company headquartered in Warminster, Pennsylvania, stands out in the healthcare sector for its innovative approach to treating infectious..

Immatics N.V. (IMTX) Stock Analysis: Exploring a 40% Upside Potential in Cutting-Edge Cancer Therapies

Immatics N.V. (NASDAQ: IMTX) is capturing significant attention in the biotech sector with its pioneering approach to cancer treatment through T cell redirecting immunotherapies. As a..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Unpacking a Potential 101% Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, Relay Therapeutics, Inc. (NASDAQ: RLAY) presents an intriguing opportunity. With a current market capitalization of $1.17 billion,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds